122 related articles for article (PubMed ID: 20446856)
1. Tiotropium therapy and mortality risk in COPD patients: the most severe, the most protected? Evaluation of Celli B, Decramer M, Kesten S, et al. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(10): 948-55.
Sampablo I; Carone M; Antoniu SA
Expert Opin Pharmacother; 2010 Jun; 11(8):1439-41. PubMed ID: 20446856
[TBL] [Abstract][Full Text] [Related]
2. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
Tashkin DP
Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
[TBL] [Abstract][Full Text] [Related]
3. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
4. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M
Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131
[TBL] [Abstract][Full Text] [Related]
5. [The verge and the abyss: tiotropium (Spiriva) in COPD].
Segel MJ; Ben-Dov I
Harefuah; 2011 Jan; 150(1):61-3, 66. PubMed ID: 21449160
[TBL] [Abstract][Full Text] [Related]
6. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
Tashkin DP
Curr Opin Pulm Med; 2010 Mar; 16(2):97-105. PubMed ID: 20019615
[TBL] [Abstract][Full Text] [Related]
7. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
Beeh KM; Welte T; Buhl R
Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
[TBL] [Abstract][Full Text] [Related]
8. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
Somand H; Remington TL
Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
[TBL] [Abstract][Full Text] [Related]
9. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].
Schuurbiers OC; Schermer TR; Dekhuijzen PN; van Weel C
Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1227-32. PubMed ID: 16796173
[TBL] [Abstract][Full Text] [Related]
10. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
[TBL] [Abstract][Full Text] [Related]
11. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
12. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
13. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis.
Wu Q; Li G; Lei WI; Zhou X
Respirology; 2009 Jul; 14(5):666-74. PubMed ID: 19402836
[TBL] [Abstract][Full Text] [Related]
16. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
[TBL] [Abstract][Full Text] [Related]
17. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of tiotropium in the prevention of exacerbations of COPD.
Anzueto A; Miravitlles M
Ther Adv Respir Dis; 2009 Jun; 3(3):103-11. PubMed ID: 19617284
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes.
Yohannes AM; Willgoss TG; Vestbo J
Respir Care; 2011 Apr; 56(4):477-87. PubMed ID: 21255503
[TBL] [Abstract][Full Text] [Related]
20. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
Niewoehner DE
COPD; 2009 Feb; 6(1):1-3. PubMed ID: 19229702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]